Designed for both Covered Entities and Manufacturers, attend this event to explore the latest developments in 340B with regards to transparency, HRSA 340B audits and other federal oversight activities. Attendees examine the impact of recent policy changes, trends in pharmacy contracting and drug management practices, how to effectively leverage data analytics, and strategies to maintain compliance and ensure program integrity.
This Summit includes tailored, closed-door sessions for Covered Entities and Manufacturers as well as shared content to maximize collaboration and knowledge -sharing.
STAY TUNED FOR EVENT UPDATES. JOIN OUR MAILING LIST.